ArticleEndocrinology2021

Mammary Tumors Growing in the Absence of Growth Hormone Are More Sensitive to Doxorubicin Than Wild-Type Tumors.

Daniel D Lantvit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.